In a new book, Steve Ramirez explores the potential of memory manipulation to ease depression and other afflictions.

For decades, the agency has redacted drug names from reports. Now, several former officials support ending the practice.

The federal government announced a new approach to regulating pharmaceutical ads. Consumers may not see a difference.

Oren Harman's "Metamorphosis" explores the minutiae of biological change and the mechanics of how life shifts forms.

Millions of women have pre-menstrual dysphoric disorder, or PMDD. But diagnoses and treatments vary considerably.

Peatlands act as a crucial climate regulator, and are increasingly at the center of conflicts over resource extraction.

Amid Trump-era funding turmoil, foundations are finding themselves pulled in many directions to fill in the gaps.

For months, agency scientists have been waiting for the Trump administration to release their final report on PFNA.

In the beginning, the Big Bang happened, sending everything in the universe expanding outward and apart, from a dense hot point. Since then, all that matter and energy has continued to move outward, ...

In 2006, a new study on antidepressants was making headlines with its promising results: Two-thirds of participants who tried various antidepressants recovered from their depression symptoms within ...